The aging thyroid

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 5, 2013, Pages 455-459

  Tabatabaie, Vafa ^a   Surks, Martin I ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

elderly; hyperthyroidism; hypothyroidism; subclinical

Indexed keywords

LEVOTHYROXINE; THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; THYROXINE;

AGING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; FINE NEEDLE ASPIRATION BIOPSY; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; OBESITY; REVIEW; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WELLBEING;

AGED; AGED, 80 AND OVER; AGING; ASYMPTOMATIC DISEASES; COGNITION DISORDERS; HUMANS; METABOLIC SYNDROME X; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES; THYROTROPIN;

EID: 84883654446     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/01.med.0000433055.99570.52     Document Type: Review

References (35)

1. Laurberg P, Andersen S, Carlé A, et al. The TSH upper reference limit: where are we at? Nat Rev Endocrinol 2011; 7:232-239.
2. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87:1068-1072. (Pubitemid 36121067)
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489-499. (Pubitemid 34158210)
4. Kratzsch J, Fiedler GM, Leichtle A, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005; 51:1480-1486. (Pubitemid 41060881)
5. Hamilton TE, Davis S, Onstad L, Kopecky KJ. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008; 93:1224-1230. (Pubitemid 351519714)
6. Eskelinen S, Suominen P, Vahlberg T, et al. The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population. Clin Chem Lab Med 2005; 43:1380-1385. (Pubitemid 41752569)
7. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation of treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8:457-469.
8. Stathatos N, Wartofsky L. Managing subclinical hypothyroidism in women. Womens Health Prim Care 2002; 5:239-246.
9. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90:5483-5488. (Pubitemid 41262320)
10. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2005; 90:5489-5496. (Pubitemid 41262321)
11. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13:3-126.
12. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92:4575-4582. (Pubitemid 350223429)
13. Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 2009; 70:788-793.
14. Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010; 95:496-502.
15. Atzmon G, Barzilai N, Hollowell JG, et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009; 94:1251-1254.
16. Kahapola-Arachchige KM, Hadlow N, Wardrop R, et al. Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol (Oxf) 2012; 77:773-779.
17. Vadiveloo T, Donnan PT, Murphy MJ, Leese GP. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: The Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab 2013; 98:1147-1153.
18. Bremner AP, Feddema P, Leedman PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012; 97:1554-1562.
19. Waring AC, Arnold AM, Newman AB, et al. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 2012; 97:3944-3950.
20. Somwaru LL, Arnold AM, Joshi N, et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009; 94:1342-1345.
21. Beydoun MA, Beydoun HA, Shroff MR, et al. Serum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey. Neurobiol Aging 2012; 33:1730-1743.
22. De Jongh RT, Lips P, van Schoor NM, et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 2011; 165:545-554.
23. Yeap BB, Alfonso H, Chubb SA, et al. Higher free thyroxine levels predict increased incidence of dementia in older men: the Health in Men Study. J Clin Endocrinol Metab 2012; 97:E2230-E2237.
24. Forti P, Olivelli V, Rietti E, et al. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. Gerontology 2012; 58:41-49.
25. Wijsman LW, de Craen AJ, Trompet S, et al. Subclinical thyroid dysfunction and cognitive decline in old age. PLoS One 2013; 8:e59199.
26. Waring AC, Rodondi N, Harrison S, et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin Endocrinol 2012; 76:911-918.
27. Heima NE, Eekhoff EM, Oosterwerff MM, et al. Thyroid function and the metabolic syndrome in older persons: a population-based study. Eur J Endocrinol 2012; 168:59-65.
28. Meyerovitch J, Rotman-Pikielny P, Sherf M, et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med 2007; 167:1533-1538. (Pubitemid 47124184)
29. Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012; 97:1962-1969.
30. Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2013; 98:533-540.
31. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011; 96:E1-E8.
32. Fortinsky P, Arnold AM, Psaty BM, Cappola AR. The natural history of subclinical hyperthyroidism in the elderly: the cardiovascular health study. 82nd Annual Meeting of the American Thyroid Association; Quebec City, Canada; 29 September 2012. [Abstract].
33. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011; 96:1344-1351.
34. Das G, Ojewuyi TA, Baglioni P, et al. Serum thyrotropin at baseline predicts the natural course of subclinical hypothyroidism. Clin Endocrinol (Oxf) 2012; 77:146-151.
35. Nanchen D, Gussekloo J, Westendorp RG, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 2012; 97:852-861.